2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | |
Interest Income | 27,227,000 | 78.514% | 15,252,000 | 10,246,000 | 12,292,000 | 16,549,000 |
Interest Expense | (19,458,000) | 154.054% | (7,659,000) | (3,448,000) | (5,440,000) | (8,882,000) |
Net Interest Income | 7,769,000 | 2.318% | 7,593,000 | 6,798,000 | 6,852,000 | 7,667,000 |
Other Operating Income | 10,250,000 | 17.479% | 8,725,000 | 7,903,000 | 7,902,000 | 7,750,000 |
Total Operating Income | 18,019,000 | 10.424% | 16,318,000 | 14,701,000 | 14,754,000 | 15,417,000 |
Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
Net Operating Income | 18,019,000 | 10.424% | 16,318,000 | 14,701,000 | 14,754,000 | 15,417,000 |
Operating Expenses | (11,551,000) | 5.846% | (10,913,000) | (10,924,000) | (10,380,000) | (10,933,000) |
Impairment Losses on Loans & Advances | (508,000) | -39.234% | (836,000) | (254,000) | (2,325,000) | (908,000) |
Other Impairment Losses | 0 | -- | 0 | 0 | 0 | 0 |
Operating Profit / (Loss) | 5,960,000 | 30.444% | 4,569,000 | 3,523,000 | 2,049,000 | 3,576,000 |
Change in FV & Impairment on Inv. Prop. | (12,000) | -76.000% | (50,000) | (106,000) | (132,000) | (122,000) |
Change in FV & Impairment on Others | (996,000) | 156.041% | (389,000) | (266,000) | (455,000) | (41,000) |
Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
Share of Results of Asso. & JCEs | 141,000 | -9.615% | 156,000 | 196,000 | 151,000 | 300,000 |
Profit / (Loss) before Taxation | 5,093,000 | 18.829% | 4,286,000 | 3,347,000 | 1,613,000 | 3,713,000 |
Taxation | (1,631,000) | 17.847% | (1,384,000) | (1,034,000) | (862,000) | (1,373,000) |
Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | 7,000 | -84.783% | 46,000 | 2,000 | (27,000) | (37,000) |
Others | -- | -- | -- | -- | -- | -- |
Profit / (Loss) Attributable to Shareholders | 3,469,000 | 17.673% | 2,948,000 | 2,315,000 | 724,000 | 2,303,000 |
2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | |
Depreciation & Amortisation | 1,071,000 | -9.696% | 1,186,000 | 1,181,000 | 1,251,000 | 1,180,000 |
Directors' Emoluments | -- | -- | -- | -- | -- | -- |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
EPS (cts) | 108.600 | 26.426% | 85.900 | 61.300 | 10.400 | 57.000 |
DPS (cts) | 27.000 | -- | 18.000 | 12.000 | 9.000 | 7.000 |
Dividend Payout Ratio (%) | 24.862% | -- | 20.955% | 19.576% | 86.538% | 12.281% |
Cash flow per share ($) | (2.002) | -- | 5.116 | 3.931 | 6.720 | (0.284) |
NBV per share ($) | 16.677 | -- | 14.910 | 14.943 | 14.538 | 14.028 |
Remarks: | Real time quote last updated: 22/11/2024 17:59 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (K$) | USD 2,378,000 |
%Change | -0.419% |
EPS / (LPS) | USD 0.833 |
NBV Per Share ($) | USD 17.405 |